Drivers of Eosinophilic COPD Exacerbations
NCT04961060 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2021-07-14
Summary
Main objective: investigate gene expression differences in nasal epithelium and sputum between eosinophilic COPD exacerbations and other subtypes.
Conditions
- COPD Exacerbation
- Eosinophilia
Sponsors & Collaborators
-
Maastricht University
collaborator OTHER - collaborator INDUSTRY
-
University Medical Center Groningen
lead OTHER
Principal Investigators
-
Maarten van den Berge, PhD · UMCG
Eligibility
- Min Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-07-31
- Primary Completion
- 2024-09-30
- Completion
- 2025-01-31
Countries
- Netherlands
Study Locations
More Related Trials
-
Causes, Characteristics and Mechanisms of Infective Exacerbations in Subjects With Asthma and Chronic Obstructive Pulmonary Disease (COPD)
NCT00512954 ·Status: COMPLETED
-
Phenotype Assessment of Blood and Airway Eosinophils in Patients With COPD and Asthma
NCT05398133 ·Status: UNKNOWN
-
Systemic Inflammation in Chronic Obstructive Pulmonary Disease (COPD)
NCT00850863 ·Status: UNKNOWN
-
Investigation on the Role of Corticosteroids and Beta-Agonists on Cytokine Production in COPD Patients
NCT00263380 ·Status: UNKNOWN
-
A Study of the Inflammatory Pathways Associated With Chronic Obstructive Pulmonary Disease Exacerbations
NCT01337661 ·Status: COMPLETED
-
Evaluation of Eosinophil Phenotype in COPD Patients
NCT04494308 ·Status: UNKNOWN
-
Using Multiomics to Define Mechanisms of Rhinovirus-induced Chronic Obstructive Pulmonary Disease Exacerbations to Develop Novel Therapies and Therapeutic Targets
NCT07112235 ·Status: RECRUITING
-
Biannual Review of Exhaled Air and Trends in Health Evaluation in COPD
NCT07045948 ·Status: RECRUITING ·Phase: NA
-
Phenotyping and Classifying Asthma Exacerbations
NCT05304039 ·Status: ACTIVE_NOT_RECRUITING
-
Markers of COPD Exacerbations
NCT05315674 ·Status: RECRUITING
-
A Cross-sectional Study of COPD and Symptom Variability in MEA Countries
NCT03425760 ·Status: COMPLETED
-
Acute Exacerbation of Chronic Obstructive Pulmonary Disease Inpatient Registry Study Stage II
NCT05032898 ·Status: UNKNOWN
-
Biomarker of Acute Exacerbation of COPD
NCT04963244 ·Status: COMPLETED
-
Asthma Breath Biomarker Assessment
NCT03084016 ·Status: COMPLETED
-
A Study to Obtain Normal Values of Inflammatory Variables From Healthy Subjects
NCT00848406 ·Status: COMPLETED
-
COPD in the Time of COVID-19
NCT04407598 ·Status: UNKNOWN
-
Exploring Clinical Predictors of COPD Exacerbation in a Community Cohort
NCT05762861 ·Status: UNKNOWN ·Phase: NA
-
Respiratory Microbiome in COPD and Associated Inmune Response.
NCT03321708 ·Status: UNKNOWN
-
Risk Prediction Model for Exacerbating Phenotype in Patients With Chronic Obstructive Pulmonary Disease
NCT06198309 ·Status: RECRUITING
-
Gene Expression Profile and Inflammation Profile of Classic Asthma, Cough Variant Asthma and Eosinophilic Bronchitis
NCT02555345 ·Status: UNKNOWN
-
Multiorgan Pathology in Chronic Obstructive Pulmonary Disease (COPD)
NCT00864994 ·Status: UNKNOWN
-
Regulation of Inflammatory Mediators in Chronic Obstructive Pulmonary Disease
NCT00147095 ·Status: COMPLETED
-
Role of Inhaler Adherence and Blood Eosinophil Count in Exacerbations of COPD
NCT05814484 ·Status: UNKNOWN
-
Epidemiology of Chronic Bronchitis in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT02128529 ·Status: COMPLETED
-
Boston Early-Onset Chronic Obstructive Pulmonary Disease (COPD) Study
NCT01177618 ·Status: RECRUITING